Cognition Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Cognition Therapeutics

24/03/2023 16:28

* Cognition Therapeutics Inc  CGTX.OQ  reported a quarterly
adjusted loss of 20 cents​​ per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for a loss of 22 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Cognition Therapeutics Inc's reported EPS for the quarter
was a
loss of 20 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cognition Therapeutics Inc shares had fallen by 12.9% this
quarter.
    * The company reported a quarterly loss of $5.18 million.
    * Wall Street's median 12-month price target for Cognition
Therapeutics Inc is $9.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 24 at 04:28 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.22          -0.20          Beat
 Sep. 30 2022      -0.38          -0.29          Beat
 Jun. 30 2022      -0.32          -0.25          Beat
 Mar. 31 2022      -0.29          -0.17          Beat